Abstract

BackgroundTocilizumab, in the registered dose of 8 mg/kg, has proven to be an effective treatment in rheumatoid arthritis (RA) patients. However, RCT data show that a substantial proportion of patients...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call